Mumbai, January 17, 2023 – Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, and the Japanese
Continue ReadingParexel and Japanese Foundation for Cancer Research Announce Strategic Alliance